ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201
-
Published:2024-03
Issue:2
Volume:4
Page:100251
-
ISSN:2667-0267
-
Container-title:JID Innovations
-
language:en
-
Short-container-title:JID Innovations
Author:
Changelian PaulORCID, Xu CanxinORCID, Mnich SteveORCID, Hope HeidiORCID, Kostecki KourtneyORCID, Hirsch JeffORCID, Loh Chin-YiORCID, Anderson DavidORCID, Blinn JamesORCID, Hockerman SusanORCID, Dick EvanORCID, Smith WalterORCID, Monahan JosephORCID, Raoof ToorajORCID, Forman SethORCID, Burt DavidORCID, Barnes BradORCID, Gordon DavidORCID, Walker NealORCID, Sudzina JohnORCID, Tucker StephenORCID, Jacobsen JonORCID
|
|